Prednicarbate (Dermatop®): Profile of a corticosteroid

Journal of Cutaneous Medicine and Surgery

Volumn 8, Issue 4, 2004, Pages 244-247

  Gupta, Aditya K ^a,b,c   Chow, Melody ^b  

^a UNIVERSITY OF TORONTO   (Canada)

^b MEDIPROBE RESEARCH INC   (Canada)

^c NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETAMETHASONE 17 PROPIONATE; BETAMETHASONE VALERATE; CORTICOSTEROID; DESOXIMETASONE; HYDROCORTISONE; HYDROCORTISONE 17 BUTYRATE 21 PROPIONATE; HYDROCORTISONE ACEPONATE; PIMECROLIMUS; PREDNICARBATE; PREDNISOLONE; TACROLIMUS; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; DRUG DERIVATIVE; GLUCOCORTICOID;

ANTIINFLAMMATORY ACTIVITY; ATOPIC DERMATITIS; BURNING SENSATION; CATARACT; CUSHING SYNDROME; DIZZINESS; DRUG EFFICACY; DRUG POTENCY; DRUG SAFETY; EDEMA; ENDOCRINE DISEASE; FOLLICULITIS; GROWTH RETARDATION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PARESTHESIA; PRIORITY JOURNAL; PRURITUS; REVIEW; RISK BENEFIT ANALYSIS; SKIN ATROPHY; SKIN DISEASE; URTICARIA; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS; DERMATITIS, ATOPIC; GLUCOCORTICOIDS; HUMANS; PREDNISOLONE;

EID: 24044520065     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-004-0120-x     Document Type: Review

References (29)

1. DJ. Trozak 1999 Topical corticosteroid therapy in psoriasis vulgaris: Update and new strategies Cutis 64 315 318
2. H Degreef A. Dooms-Goossens 1993 The new corticosteroids: Are they effective and safe? Dermatol Clin 11 155 160
3. Dermatop®, Emollient Cream (prednicarbate emollient cream 0.1%) U.S. prescribing information. Dermik Laboratories, Berwyn, PA, May 2003.
4. MJ Kerscher HC. Korting 1992 Topical glucocorticoids of the non-fluorinated double-ester type: Lack of atrophogenicity in normal skin as assessed by high-frequency ultrasound Acta Derm Venereol 72 214 216
5. HC Korting E Hulsebus M Kerscher 1995 Discrimination of the toxic potential of chemically differing topical glucocorticoids using a neutral red release assay with human keratinocytes and fibroblasts Br J Dermatol 133 54 59
6. K Lange B Kleuser A Gysler 2000 Cutaneous inflammation and proliferation in vitro differential effects and mode of action of topical glucocorticoids Skin Pharmacol Appl Skin Physiol 13 93 103
7. R Hein C Mauch A Hatamochi 1988 Influence of corticosteroids on chemotactic response and collagen metabolism of human skin fibroblasts Biochem Pharmacol 37 2723 2729
8. K Lange A Gysler M Bader 1997 Prednicarbate versus conventional topical glucocorticoids: Pharmacodynamic characterization in vitro Pharm Res 12 1744 1749
9. A Gysler B Kleuser W Sippl 1999 Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin Pharm Res 16 1386 1391
10. J Hanifin BB Abrams RJ. Cherill 1994 Management of atopic dermatitis with prednicarbate emollient cream 0.1%, a nonhalogenated prednisolone derivative J Geriatr Dermatol 2 4 119 127
11. M Schafer-Korting HC Korting MJ Kerscher 1993 Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids Clin Pharmacol Ther 54 448 456
12. T. Moshang 2001 Prednicarbate emollient cream 0.1% in pediatric patients with atopic dermatitis Cutis 68 63 69
13. Schmitt EW, Hohler T, Worms G. Long-term observation of the therapy with prednicarbate [in German]. Z Hautkr 1989; 64 (Supp. 1): 56-60.
14. In: Spencer CM, Wagstaff AJ. Prednicarbate: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. BioDrugs 1998; 9: 61-86.
15. Schulz H. Investigation of the efficacy of halogen-free prednicarbate as compared to a fluorinated standard corticoid - an intra-individual half-sided double blind study [in German]. Z Hautkr 1989; 64(Suppl. 1): 40-46.
16. In: Spencer CM, Wagstaff AJ. Prednicarbate: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. BioDrugs 1998; 9: 61-86.
17. Ulrich R, Andresen I. Double-blind comparative trial involving 0.5% halomethasone (Sicorten®) cream versus 0.25% prednicarbate cream in patients with acute episodes of atopic dermatitis [in German]. Fortschr Med 1991; 109: 741-744.
18. In: Spencer CM, Wagstaff AJ. Prednicarbate: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. BioDrugs 1998; 9: 61-86.
19. Nolting S, Glowania H-J, Grander K, et al. Therapie des atopischen ekzems im kindesalter. Ergebnisse einer kontrollierten studie mit den topischen kortikosteroids-zubereitungen momtaso und prednikarbat. Kinderarzt 1991; 22: 1691-1694.
20. In: Spencer CM, Wagstaff AJ. Prednicarbate: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. BioDrugs 1998; 9: 61-86.
21. Herz X, et al. An open study with HOE 777 0.25% emollient cream in children aged 1 to 12 years with contact dermatitis, atopic dermatitis, seborrheic eczema or psoriasis. Barcelona, Spain: Laboratories Novag (Grupo Ferrer), 1997.
22. In: Spencer CM, Wagstaff AJ. Prednicarbate: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. BioDrugs 1998; 9: 61-86.
23. Herz X, et al. An open study with HOE 777 0.25% emollient cream in children up to 1 year with seborrheic eczema. Barcelona, Spain: Laboratories Novag (Grupo Ferrer), 1997.
24. In: Spencer CM, Wagstaff AJ. Prednicarbate: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. BioDrugs 1998; 9: 61-86.
25. RC Cornell RJ Cherill BB. Abrams 1994 Safety of prednicarbate emollient cream 0.1% and ointment 0.1%, nonhalogenated, midpotency topical steroid formulations J Geriatr Dermatol 2 57 65
26. M Matura A. Goosens 2000 Contact allergy to corticosteroids Allergy 55 698 704
27. S Coopman H Degreef A. Dooms-Goosens 1989 Identification of cross-reaction patterns in allergic contact dermatitis from topical corticosteroids Br J Dermatol 121 27 34
28. Dermatop® Emollient Cream (prednicarbate emollient cream) 0.1% and Dermatop® E Emollient Ointment (prednicarbate ointment) 0.1% U.S. package insert. Dermik Laboratories Berwyn, PA, June 2002.
29. Dermatop® Oinment (prednicarbate Oinment 0.1%) and Dermatop® Emollient Cream (prednicarbate emollient cream 0.1%) Canadian package insert. Dermik Laboratories Canada, Inc., Mississauga, ON, Canada, November 15, 2000.